BDSX
HEALTHCAREBiodesix Inc
AI Insight
What's Moving BDSX Today?
No stock-specific AI insight has been generated for BDSX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.01$20.21
$19.16
Fundamentals
Market Cap$180M
P/E Ratio—
EPS$-3.96
Dividend Yield—
Dividend / Share—
ROE-316.5%
Profit Margin-33.3%
Debt / Equity—
Trading
Volume88K
Avg Volume (10D)—
Shares Outstanding10.4M
BDSX News
22 articles- Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains?Yahoo Finance·Jun 19, 2026
- Are Medical Stocks Lagging Biodesix (BDSX) This Year?Yahoo Finance·Jun 15, 2026
- Zacks Industry Outlook Highlights BrightSpring Health Services, Biodesix and HealthEquityYahoo Finance·Jun 9, 2026
- 3 Medical Service Industry Stocks Thriving Amid Workforce ChallengesYahoo Finance·Jun 8, 2026
- Are Medical Stocks Lagging Adicet Bio (ACET) This Year?Yahoo Finance·May 28, 2026
- Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to TradeYahoo Finance·May 25, 2026
- Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue AssumptionsYahoo Finance·May 23, 2026
- Biodesix (NASDAQ: BDSX) registers 375,000 shares for Perceptive resaleStock Titan·May 22, 2026
- Biodesix to Participate in Upcoming Investor ConferencesGlobeNewswire Inc.·May 21, 2026
- Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?Yahoo Finance·May 12, 2026
- Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing StrategyYahoo Finance·May 11, 2026
- Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?Yahoo Finance·May 7, 2026
- Biodesix, Inc. Q1 2026 Earnings Call SummaryMoby·May 5, 2026
- Biodesix (BDSX) Q1 2026 Earnings TranscriptMotley Fool·May 4, 2026
- Biodesix Q1 Earnings Call HighlightsMarketbeat·May 4, 2026
- Biodesix BDSX Q2 2025 Earnings Call TranscriptMotley Fool·May 4, 2026
- Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 4, 2026
- Biodesix Announces First Quarter 2026 Results and HighlightsYahoo Finance·May 4, 2026
- Are Medical Stocks Lagging Aura Biosciences (AURA) This Year?Yahoo Finance·Apr 22, 2026
- LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?Yahoo Finance·Apr 21, 2026
- Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026GlobeNewswire Inc.·Apr 20, 2026
- How Recent Shifts Are Reframing The Biodesix (BDSX) Investment StoryYahoo Finance·Apr 17, 2026
All 22 articles loaded
Price Data
Open$17.38
Previous Close$17.35
Day High$19.16
Day Low$16.51
52 Week High$20.21
52 Week Low$5.01
52-Week Range
$5.01$20.21
$19.16
Fundamentals
Market Cap$180M
P/E Ratio—
EPS$-3.96
Dividend Yield—
Dividend / Share—
ROE-316.5%
Profit Margin-33.3%
Debt / Equity—
Trading
Volume88K
Avg Volume (10D)—
Shares Outstanding10.4M
About Biodesix Inc
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—